Search for Clinical Trial Results

Sponsored By

Congenital Erythropoietic Porphyria - 12 Studies Found

Status Study
Completed Study Name: Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Date: 2012-04-05
Interventions:
  • Drug: Hydroxychloroquine 100 m
Completed Study Name: Risk Factors of Porphyria Cutanea Tarda (PCT)
Condition: Porphyria Cutanea Tarda
Date: 2005-09-13
Completed Study Name: Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Date: 2008-01-10
Interventions: Drug: Deferasirox 250 mg of deferasirox once daily for 6 months
Not yet recruiting Study Name: Studies in Porphyria I: Characterization of Enzyme Defects
Condition: Porphyria
Date: 1999-10-18
Completed Study Name: Study of Nutritional Factors in Porphyria
Condition: Porphyria
Date: 2000-02-24
Completed Study Name: Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
Condition: Porphyria
Date: 1999-10-18
Interventions: Drug: luteinizing hormone-releasing factor
Active, not recruiting Study Name: EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
Condition: Acute Hepatic Porphyria
Date: 2014-09-11
Completed Study Name: Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria
Condition: Porphyria
Date: 1999-10-18
Interventions:
  • Drug: heme arginate
  • Drug: tin mesoporphyri
Completed Study Name: Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria
Condition: Porphyria
Date: 1999-10-18
Interventions:
  • Drug: heme arginate
  • Drug: tin mesoporphyri
Completed Study Name: Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Date: 2011-01-26
Interventions: Drug: Exjade Orodispersible Tablet, 10 mg/Kg/day ± 5 mg/Kg/day during 24 weeks Deferasirox should b
Next >>>